Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.

Publication Title

Clin Epigenetics

Document Type

Article

Publication Date

7-29-2022

Keywords

california; sjci; santa monica

Clinical Institute

Women & Children

Clinical Institute

Cancer

Specialty/Research Institute

Oncology

Share

COinS